Chemours Company (CC) Up More than 12% Since Q3, Here’s What Wall Street Thinks About the Stock

Core Viewpoint - The Chemours Company (NYSE:CC) is recognized as one of the Best Small Cap Value Stocks to Buy, with a share price increase of over 12% since its fiscal Q3 2025 results, despite subpar earnings and a mixed outlook from Wall Street [1]. Financial Performance - In fiscal Q3 2025, Chemours reported a 0.40% year-over-year decrease in revenue to $1.50 billion, falling short of expectations by $2.98 million [3]. - The earnings per share (EPS) of $0.20 was below analysts' consensus by $0.04 [3]. - The decline in revenue was primarily due to a 36% decrease in net sales of Freon Refrigerants and a 16% decrease in net sales of Foam, Propellants & Other [3]. - This negative performance was partially offset by an 80% year-over-year increase in net sales of Opteon™ Refrigerants, which reached $560 million [3]. Analyst Ratings and Price Targets - J.P. Morgan's Jeffrey Zekauskas reiterated a Hold rating on Chemours and lowered the price target from $15 to $13 [2]. - Alembic Global's Hassan Ahmed also lowered the price target from $20 to $19 while maintaining a Buy rating [2]. Market Challenges and Management Response - Analysts at Truist Financial noted demand challenges in the Titanium Technologies and industrial markets within Advanced Performance Materials [4]. - Despite these challenges, analysts expressed confidence in management's efforts to right-size production and preserve cash flow under tough market conditions [4]. Company Overview - Chemours provides performance chemicals and delivers solutions across various markets, including plastics, semiconductors, consumer electronics, coatings, transportation, refrigeration and air conditioning, and general industrial [5].